logo
Citizenship Considerations For Business Leaders In The Caribbean

Citizenship Considerations For Business Leaders In The Caribbean

Forbes20-03-2025

Jean-François Harvey, Founder and Managing Partner of Harvey Law Group, an international law firm specializing in investment immigration.
getty
Caribbean countries have long enticed business leaders and investors seeking their slice of island paradise. Growing economic opportunities have brought further attention to the region in recent years. Caribbean citizenship by investment (CBI) programs have emerged as a popular pathway to citizenship.
Before starting the journey to secondary citizenship, it is essential for business leaders and investors to understand the application process and consider key factors for success:
In the Caribbean, prospective applicants are presented with various contribution options, usually an investment or a donation, each with its own set of considerations:
Individuals seeking a tangible investment asset and potential rental income can meet the investment requirement through a real estate purchase. Many looking to invest in the Caribbean real estate market look at the location, quality and the potential return on investment for available properties.
However, prospective investors may be required to pay additional fees to the country for CBI eligibility. For instance, Dominica's CBI program requires a minimum real estate investment of $200,000, plus government due diligence and application fees, which vary depending on the number of dependents to be included.
In some cases, entrepreneurs can apply if they invest in a new business in the Caribbean or relocate an existing business. This route may be attractive to those looking to venture into new markets or those seeking active involvement in local business communities. Such businesses may also benefit from lower costs, a skilled marketplace and access to the CARICOM free trade area.
Investors seeking a low-risk investment option or those interested in supporting economic development initiatives may wish to purchase government bonds. This provides a useful option to investors that wish to prioritize capital preservation and allows for simpler recovery and exit-strategy of the investment, as this option provides a guaranteed means of recovering capital.
Government bonds will be subject to a holding requirement and generally do not pay interest, so inflation on the investment's real value, and costs of the capital, should be considered.
Individuals seeking a straightforward route without the complexities of managing investments may want to consider donations to a government fund. Antigua and Barbuda's CBI program, as an example, requires a donation of $230,000 to its National Development Fund.
This option may be most suitable for business leaders who want the simplest process and the least impact on tax return filings, as no asset that must be reported is acquired.
Donating to a government approved fund may be an attractive option to conscientious business leaders. By contributing to a government approved fund, business leaders may directly contribute to the local economy and the development of initiatives for the further benefit of the host country.
It is important to note that time frames can vary depending on the country, the citizenship of the applicant, the number of dependents included and the time needed by the government to verify the information provided by the applicant.
From my experience, currently average application processing times hover around nine to 12 months from application submission to obtaining citizenship, due to application backlogs and price increases imposed in 2024.
Applying for secondary citizenship demands meticulous attention to detail. Incomplete documentation and discrepancies in application details can create significant hurdles. Issues can also arise from background checks, such as criminal and financial record checks.
Common issues that may lead to rejections or delays include failing to comply with due diligence disclosure requirements, failing to fully demonstrate a source of funds, disorganized or improperly translated and legalized documents. The type of documentation required often vary depending on various factors, such as the source of the investment funds, in which further documentation could be required. Not having the right expertise and a lack of experience with the CBI process can cause delays and sometimes even rejection.
I've found full disclosure is the best way to mitigate potential pitfalls—particularly with regard to ownership of business entities, where a failure to disclose shareholdings or directorships of various companies can be a reason for refusal. To safeguard against unforeseen obstacles, engaging the expertise of qualified investment migration attorneys is recommended. (Disclosure: My law firm helps with this, as do others.)
For many applicants, acquiring secondary citizenship has some impact on their existing citizenship. Dual citizenship policies vary among countries, with some countries mandating renunciation of existing citizenship.
Ongoing tax obligations and required tax filings are another important consideration. Consultation with certified tax professionals can help applicants with the guidance they need to safeguard financial interests.
Secondary citizenship in the Caribbean offers an array of benefits, but every country and CBI program has its nuances. Variations in healthcare provisions, educational opportunities and visa-free travel privileges underscore the importance of informed decision-making. Making a list of preferences and priorities can help serve as a compass to guide business leaders toward the jurisdiction that best aligns with their aspirations.
It's a good idea for business leaders and entrepreneurs to seek professional advice if they are planning to establish new businesses in Caribbean jurisdictions, particularly with regard to taxes and duties, banking services, legal and regulatory considerations, as well as access to skilled labor resources.
Obtaining alternative citizenship may be useful for entrepreneurs as it opens borders for them to expand their business into the booming local economies in the Caribbean. If a CBI application is successful, entrepreneurs could not only reside, work and settle in the country that they are applying for but also reside, work and settle across many other Caribbean countries if those countries are CARICOM Single Market and Economy (CSME) member states. Further, many of these jurisdictions also have attractive tax policies including low business taxes, no wealth tax, capital gains tax or inheritance tax, and in several jurisdictions there is no income tax (automatic download).
Aspiring citizens must arm themselves with knowledge, complete the application process with clarity and diligence, and have patience.
The information provided here is not investment, tax or financial advice. You should consult with a licensed professional for advice concerning your specific situation.
Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hyundai pitches hybrids as ‘Best of Both Worlds' in Paris, Texas
Hyundai pitches hybrids as ‘Best of Both Worlds' in Paris, Texas

Yahoo

time2 hours ago

  • Yahoo

Hyundai pitches hybrids as ‘Best of Both Worlds' in Paris, Texas

This story was originally published on Marketing Dive. To receive daily news and insights, subscribe to our free daily Marketing Dive newsletter. Hyundai launched a marketing campaign, 'Best of Both Worlds,' in support of its Sante Fe and Tuscon hybrid vehicles, per a press release. Two ad spots and two long-form videos feature a French cowboy who lives in Paris, Texas and drives Hyundai's hybrids. A separate campaign, 'He Got Money,' focuses on fuel savings and is targeted at an African-American audience. The campaigns, from Innocean USA and Culture Brands, respectively, come as the automaker has seen hybrid vehicle sales increase 44% so far in 2025, despite ongoing macroeconomic uncertainty. Hyundai is going all-in on its hybrid vehicles with a pair of ads that mix humor and value propositions like performance and savings. The automaker has seen a big boost in hybrid vehicle sales, with total hybrid vehicle sales jumping 5% in May, per details shared with Marketing Dive. The 'Best of Both Worlds' effort focuses on Jean-Luc, a cowboy born in Paris, France who lives in Paris, Texas. A 30-second 'Cowboy' spot which debuted on June 8 during the NBA finals focuses on the Sante Fe Hybrid and shows how the titular character can have 'more cheese' on his plate by saving on fuel. 'Mosey' focuses on the Tucson Hybrid and will air later this month. In addition, a long-form YouTube spot has a cinematic feel, albeit one drawn more from Westerns and not Wim Wenders' art house classic 'Paris, Texas.' However, the campaign was filmed on location in the Texas town, and Hyundai will donate an estimated $30,000 from production to support local schools in the community. Created by Innocean with media by Canvas, 'Best of Both Worlds' will run across broadcast, digital and programmatic platforms, with custom digital content on TikTok, Meta, Reddit, YouTube and beyond. In a separate but related effort, Hyundai continued its series of 'Okay Hyundai' ads with 'He Got Money.' The 30-second ad focuses on a character who owns a hybrid and the gossip about his seemingly extravagant lifestyle, which — in a nod to ongoing price pressures — includes a fridge full of eggs. 'He Got Money' will run across broadcast and digital platforms in both 15- and 30-second formats and will be featured in influencer partnerships. The ad, which is targeted at an African-American audience, features Kathleen Bradley — best known as Mrs. Parker from the cult classic "Friday' — and is from Hyundai's African American agency of record, Culture Brands. ''He Got Money' shows how the Tucson Hybrid empowers drivers to enjoy more of what matters—style, comfort, and community—thanks to real savings at the pump,' said Erik Thomas, director of experiential and multicultural marketing, Hyundai Motor America, in a press release. Hyundai's increased hybrid sales follow the automaker becoming the launch partner of Amazon Autos late last year. One global auto brand moved approximately $80 million in annual ad spend from The Trade Desk to Amazon's ad platform by the end of Q1, partially due to its ability to sell its cars via the online retailer, Adweek reported. Hyundai is currently the only automaker that has that functionality on Amazon. Recommended Reading Mattel's Hot Wheels ignites 'challenger spirit' with cinematic ad

BNP Paribas to shutter 200 branches in France by 2027
BNP Paribas to shutter 200 branches in France by 2027

Yahoo

time14 hours ago

  • Yahoo

BNP Paribas to shutter 200 branches in France by 2027

BNP Paribas is reportedly planning to reduce its network of retail branches in France as part of a strategy to enhance profitability. Its CEO Jean-Laurent Bonnafe confirmed that the bank intends to close approximately 80 branches this year, followed by an additional 120 in the next year, reported Bloomberg. Reports from French newspaper Les Echos suggest that the total number of branch closures could reach approximately 500 by 2030. This move is expected to lead to a 5% annual reduction in branch staff, while the bank aims to increase employment in online and telephone banking services. Discussions with labour unions regarding this strategy, which was first communicated in March, are ongoing. Sources familiar with the situation indicated that impacted staff will be offered alternative roles within the organisation. Besides, BNP Paribas is relying on natural attrition to manage workforce reductions without resorting to layoffs. A spokesperson for BNP Paribas stated: 'We presented in March an ambitious growth plan to trade unions that outlines a strategic roadmap and related investments for our Commercial & Personal Banking in France. Every employee of the bank has their place in this project.' The restructuring is part of Bonnafe's focus on revitalising the retail banking sector, which has faced challenges due to local regulations and the European Central Bank's monetary policies. Isabelle Loc, who was appointed to lead the retail banking division following the departure of Marguerite Berard, is expected to leverage the digital platform Hello bank and private banking services to drive growth. The bank currently operates around 1,500 branches in France, and under Loc's strategy, some branch functions will be shifted to remote customer service centres, with employees being offered new positions. BNP Paribas plans to reveal further details about its restructuring strategy by the end of June. In April this year, BNP Paribas extended its partnership with IBM Cloud for another ten years to enhance its cloud-native strategy and advance generative artificial intelligence (GenAI) capabilities. "BNP Paribas to shutter 200 branches in France by 2027" was originally created and published by Retail Banker International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio

Keros Announces Return of $375 Million in Excess Capital to Stockholders
Keros Announces Return of $375 Million in Excess Capital to Stockholders

Yahoo

time15 hours ago

  • Yahoo

Keros Announces Return of $375 Million in Excess Capital to Stockholders

Concludes Strategic Alternatives Review and Provides Update on Development of KER-065 LEXINGTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ('Keros' or the 'Company') (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta ('TGF-ß') family of proteins, today announced that the Company has concluded its previously announced review process to evaluate strategic alternatives to maximize stockholder value for the Company. As a result of this process, the Company's Board of Directors (the 'Board') unanimously determined to initiate a process to return $375 million of excess capital to stockholders. The terms and structure of this capital return remain under consideration and are expected to be announced at a future date. Jean-Jacques Bienaimé, Lead Independent Director, said, 'Our Board and management team are taking action to enhance stockholder value. To that end, we intend to return a significant amount of excess capital to stockholders while continuing to pursue development of our lead product candidate, KER-065, for the treatment of neuromuscular diseases, with an initial focus on Duchenne muscular dystrophy. This reflects a thorough review of our capital requirements, feedback from our stockholders, and our confidence in the potential for Keros to provide meaningful and potentially disease-modifying benefits to patients.' During the strategic review process, the Board, with the assistance of the strategic committee of the Board and outside financial and legal advisors, evaluated a comprehensive range of strategic alternatives, including but not limited to a sale of the Company or other business combination transaction, continued investment in the Company's pipeline, and/or return of excess capital to stockholders. The evaluation of these alternatives involved outreach to a number of third parties and engagement with Company stockholders. This press release is not an offer to sell or a solicitation of an offer to buy any of the Company's securities. About Keros Therapeutics, Inc. Keros is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the TGF-ß family of proteins. Keros is a leader in understanding the role of the TGF-ß family of proteins, which are master regulators of the growth, repair and maintenance of a number of tissues, including blood, bone, skeletal muscle, adipose and heart tissue. By leveraging this understanding, Keros has discovered and is developing protein therapeutics that have the potential to provide meaningful and potentially disease-modifying benefit to patients. Keros' lead product candidate, KER-065, is being developed for the treatment of neuromuscular diseases, with an initial focus on Duchenne muscular dystrophy. Keros' most advanced product candidate, elritercept (KER-050), is being developed for the treatment of cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndrome and in patients with myelofibrosis. Cautionary Note Regarding Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as 'anticipates,' 'believes,' 'continue,' 'expects,' 'enable,' 'intention,' 'potential' and 'will' or similar expressions are intended to identify forward-looking statements. Examples of these forward-looking statements include statements concerning the intention, terms, structure and timing of return of excess capital by the Company. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among others: the terms and structure of the capital return; the timing of the capital return; the risk that the capital return could have an adverse effect on the ability of the Company to retain and hire key personnel and maintain relationships with partners, suppliers, employees, stockholders and other business relationships and on its operating results and business generally; the risk of any litigation relating to the strategic review; Keros' limited operating history and historical losses; Keros' ability to raise additional funding to complete the development and any commercialization of its product candidates; Keros' dependence on the success of its product candidates, KER-065 and elritercept; that Keros may be delayed in initiating, enrolling or completing any clinical trials; competition from third parties that are developing products for similar uses; Keros' ability to obtain, maintain and protect its intellectual property; and Keros' dependence on third parties in connection with manufacturing, clinical trials and preclinical studies. These and other risks are described more fully in Keros' filings with the Securities and Exchange Commission (the 'SEC'), including the 'Risk Factors' section of the Company's Quarterly Report on Form 10-Q, filed with the SEC on May 6, 2025, and its other documents subsequently filed with or furnished to the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, Keros undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. Contacts Investor Contact:Justin Frantzjfrantz@ Media Contact:Mahmoud Siddig / Adam Pollack / Viveca TressJoele Frank, Wilkinson Brimmer Katcher(212) 355-4449Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store